Neurocrine Biosciences Inc. shares dived 18.53 percent on Friday, a third consecutive day, as investors digested the ...
Neurocrine Biosciences (($NBIX)) has held its Q4 earnings call. Read on for the main highlights of the call. Neurocrine Biosciences’ earnings call ...
One way to get an idea of the market sentiment on a stock is to check its rate of institutional ownership. In the case of ...
Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
New CABI-led research using publicly-shared DNA barcodes and citizen science images have provided new evidence on the establishment and spread of a biological control agent used for the control of the ...